Hikma Pharmaceuticals Plc (HKMPF)
22.19
0.00 (0.00%)
USD |
OTCM |
Sep 16, 16:00
Hikma Pharmaceuticals Market Cap : 4.698B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 4.698B |
| September 15, 2026 | 4.698B |
| September 14, 2026 | 4.698B |
| September 11, 2026 | 4.698B |
| September 10, 2026 | 4.698B |
| September 09, 2026 | 4.698B |
| September 08, 2026 | 4.698B |
| September 04, 2026 | 4.698B |
| September 03, 2026 | 4.698B |
| September 02, 2026 | 4.698B |
| September 01, 2026 | 4.698B |
| August 31, 2026 | 4.698B |
| August 28, 2026 | 4.698B |
| August 27, 2026 | 4.698B |
| August 26, 2026 | 4.698B |
| August 25, 2026 | 4.698B |
| August 24, 2026 | 4.698B |
| August 21, 2026 | 4.698B |
| August 20, 2026 | 4.698B |
| August 19, 2026 | 4.698B |
| August 18, 2026 | 4.698B |
| August 17, 2026 | 4.698B |
| August 14, 2026 | 4.717B |
| August 13, 2026 | 4.717B |
| August 12, 2026 | 4.717B |
| Date | Value |
|---|---|
| August 11, 2026 | 4.717B |
| August 10, 2026 | 4.717B |
| August 07, 2026 | 4.717B |
| August 06, 2026 | 4.565B |
| August 05, 2026 | 4.565B |
| August 04, 2026 | 4.565B |
| August 03, 2026 | 4.565B |
| July 31, 2026 | 4.565B |
| July 30, 2026 | 4.565B |
| July 29, 2026 | 4.565B |
| July 28, 2026 | 4.500B |
| July 27, 2026 | 4.500B |
| July 24, 2026 | 4.313B |
| July 23, 2026 | 4.313B |
| July 22, 2026 | 4.313B |
| July 21, 2026 | 4.313B |
| July 20, 2026 | 4.313B |
| July 17, 2026 | 4.502B |
| July 16, 2026 | 4.502B |
| July 15, 2026 | 4.502B |
| July 14, 2026 | 4.502B |
| July 13, 2026 | 4.502B |
| July 10, 2026 | 4.502B |
| July 09, 2026 | 4.594B |
| July 08, 2026 | 4.259B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 505.23B |
| GSK Plc | 101.72B |
| Allergy Therapeutics Plc | 921.22M |
| Shield Therapeutics Plc | 91.58M |
| Futura Medical Plc | 1.512M |
Market Cap Related Metrics
| PE Ratio | 12.57 |
| PS Ratio | 1.424 |
| PEG Ratio | 0.3265 |
| Price to Free Cash Flow | 47.25 |
| Price | 22.19 |
| Earnings Yield | 7.96% |
| PEGY Ratio | 0.2966 |
| Operating PE Ratio | 7.264 |
| Normalized PE Ratio | 11.49 |